Jorge Rosenfeld

Title: Innovations of Jorge Rosenfeld in Pharmaceutical Development

Introduction

Jorge Rosenfeld is a notable inventor based in Baziege, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of drugs aimed at preventing tumor cell proliferation. His work is characterized by a focus on innovative chemical compounds that can effectively combat cancer.

Latest Patents

Rosenfeld holds a patent for the "Use of amines to produce drugs for preventing tumor cell proliferation." This invention relates to the use of compounds capable of displacing tritiated cis-N-cyclohexyl-N-ethyl [3-(3-chloro-4-cyclohexylphenyl)-allyl] amine from its receptors. The patent outlines the preparation of pharmaceutical compositions intended to combat cell proliferation, showcasing his commitment to advancing cancer treatment.

Career Highlights

Throughout his career, Jorge Rosenfeld has been associated with Sanofi-Synthelabo, a leading global pharmaceutical company. His work there has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry. With a focus on innovative solutions, he has played a vital role in the advancement of drug formulations.

Collaborations

Rosenfeld has collaborated with esteemed colleagues such as Jean C Breliere and Pascual Ferrara. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the impact of their research.

Conclusion

Jorge Rosenfeld's contributions to pharmaceutical innovation, particularly in cancer treatment, highlight his role as a significant inventor in the field. His patent and collaborations reflect a dedication to improving health outcomes through scientific advancements.